CM
MD icon

CastleKnight Management’s Pediatrix Medical MD Stock Holding History

CastleKnight Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Sell
405,866
-236,170
-37% -$5.37M 0.14% 105
2026
Q1 		$13.7M Buy
642,036
+245,970
+62% +$5.12M 0.23% 64
2025
Q4 		$8.47M Sell
396,066
-285,934
-42% -$5.86M 0.19% 71
2025
Q3 		$11.4M Sell
682,000
-24,250
-3% -$363K 0.23% 62
2025
Q2 		$10.1M Buy
706,250
+292,350
+71% +$4.01M 0.29% 55
2025
Q1 		$6M Sell
413,900
-11,200
-3% -$159K 0.24% 68
2024
Q4 		$5.58M Sell
425,100
-232,221
-35% -$3.21M 0.16% 74
2024
Q3 		$7.62M Buy
657,321
+234,796
+56% +$2.21M 0.31% 40
2024
Q2 		$3.19M Buy
+422,525
New +$3.5M 0.16% 102
2023
Q3 		– Sell
-85,400
Closed -$1.21M – 334
2023
Q2 		$1.21M Hold
85,400
– – 0.13% 122
2023
Q1 		$1.27M Buy
+85,400
New +$1.29M 0.13% 112

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

CastleKnight Management's MD Position: Q2 2026 in Review

CastleKnight Management reduced its Pediatrix Medical (MD) stake by 37% in Q2 2026, selling an estimated $5.37M and leaving 405,866 shares worth $10.3M. The position accounts for 0.14% of the portfolio, ranked #105.

CastleKnight Management first reported a position in MD in Q1 2023 and has held it in 11 quarters since. The position peaked at $13.7M in Q1 2026. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • CastleKnight Management held 405,866 shares of Pediatrix Medical worth $10.3M as of Q2 2026.
  • CastleKnight Management sold 236,170 Pediatrix Medical shares in Q2 2026, an estimated $5.37M.
  • Pediatrix Medical made up 0.14% of CastleKnight Management's portfolio in Q2 2026, its #105 holding.
  • CastleKnight Management first reported a position in Pediatrix Medical in Q1 2023 and has held it in 11 quarters since.
  • CastleKnight Management's Pediatrix Medical position peaked at $13.7M in Q1 2026.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on CastleKnight Management's 13F filing for Q2 2026, filed 14 Aug 2026.